FDA scrutinizing safety of asthma drug Xolair

The Food and Drug Administration announced Thursday it is conducting a safety review of the asthma drug Xolair after data from an ongoing study suggested an increased number of heart attacks and strokes among patients who use it.

Add to: del.icio.us | Digg